MASON, Ohio and SAN FRANCISCO, May 29, 2019 /PRNewswire/ — Ensemble Health Partners (“Ensemble” or “the Company”), an industry-leading national revenue cycle management provider, announced today that Bon Secours Mercy Health will sell 51 percent of the equity in Ensemble to Golden Gate Capital, a leading private equity investment firm. Bon Secours Mercy Health will continue as a commercial partner to Ensemble, as well as remain a minority owner in the Company and continue to serve on the Company’s board.

Founded in 2014, Ensemble partners with hospitals across the United States to create real and lasting value through revenue cycle outsourcing and other services aimed at improving healthcare operations. The Ensemble leadership team is differentiated by its extensive experience as hospital and physician practice operators, as well as its hands-on, client-first mindset. Addressing the shift to value-based care and the changing regulatory landscape, Ensemble’s proven collaborative partnership approach uses operational and process best practices, analytics and technology to craft comprehensive solutions for its clients.

With the exponential growth Ensemble has achieved, Golden Gate Capital’s investment will ensure continued delivery of exceptional results for current and future partners through enhancements in technology, services and people. The transaction facilitates the next phase of growth for Ensemble, which has grown to 3,600 employees serving customers in 30 states, and more than 60 full outsource partner hospitals. Ensemble’s current management team and best-in-class associates, along with its culture of transparency and mission to improve the quality and affordability of healthcare, will remain central to the Company’s and Golden Gate Capital’s long-term growth strategy. Following the close of the transaction, Ensemble is expected to be conservatively leveraged to ensure continued stability.

“Healthcare and the relationship between providers and payors are becoming increasingly complex, and the demand for our services is expanding significantly,” said Judson Ivy, founder and CEO of Ensemble. “This partnership will support our continued growth and allow us to invest in new technologies, positioning Ensemble as a leading innovator in our field and allowing us to continue to deliver outstanding results and best-in-class services. This is not a sale of the Company, but the addition of a new value enhancing investment partner that is fully committed to our philosophy and mission. We are confident Golden Gate Capital is the right partner as we embark on this exciting next chapter and look forward to what we can achieve together.”

Ensemble credits its associates for its exceptional growth and believes in putting its associates first, last, and always. “We believe that people are the most important part of our success,” continued Ivy. “When you take care of your people, they pay it forward by continuing to deliver outstanding results and best-in-class service.”

Rishi Chandna, Managing Director at Golden Gate Capital, said, “Ensemble has established itself as the clear leader in revenue cycle management and is highly respected for its approach, as it partners with clients, identifies the root cause of issues within the revenue cycle and provides customized, innovative solutions for its clients’ future success. The Company is also differentiated by its commitment to empower both its people and its clients to realize their full potential and create a better, more sustainable healthcare system. Ensemble is incredibly well positioned to continue its outstanding growth, and we have the utmost confidence in Judson and the world-class Ensemble team. We look forward to working with Bon Secours Mercy Health to collectively support Ensemble’s growth in the years ahead.”

This transformational and unique transaction helps Bon Secours Mercy Health continue to fulfill its Mission. The sale of Ensemble shares will deliver cash at closing and provide ongoing cash distributions to Bon Secours Mercy Health. These proceeds will ensure the ministry can continue to make significant investments in the communities it serves, providing better access to high quality healthcare for all.

“As the health care category continues to experience dramatic shifts, it is more essential than ever to work efficiently and effectively with healthcare partners to help ensure a positive patient experience through every point in the care process. Since its inception, Ensemble has worked with a myriad of clients to bring excellence to their daily operations,” said Bon Secours Mercy Health President and CEO John M. Starcher, Jr. “This strategic infusion of additional capital will help Ensemble continue to expertly serve clients, while helping ensure Bon Secours Mercy Health can continue to improve the health and well-being of the communities we’re privileged to serve for generations to come.”

This deal is subject to standard regulatory approvals.

Guggenheim Securities served as exclusive strategic and financial advisor to Bon Secours Mercy Health and Ensemble throughout the process of securing the investment.

About Ensemble Health Partners: Now more than ever, a healthy revenue cycle is essential to survival, requiring innovative approaches and impeccable coordination. At Ensemble, we’ve assembled a team of talented and passionate operators who know our field firsthand. We partner with our clients, rolling up our sleeves to build real relationships, dig deep into the details and find solutions that deliver results that last. Ensemble specializes in full revenue cycle outsource solutions, denials and underpayments, analytics and workflow optimization, Epic optimization and management services designed to identify immediate wins and create sustainable solutions that ensure long-term results. For more information, visit www.EnsembleHP.com.

About Golden Gate Capital: Golden Gate Capital is a San Francisco-based private equity investment firm with over $15 billion of capital under management. The principals of Golden Gate Capital have a long and successful history of investing across a wide range of industries and transaction types, including going-privates, corporate divestitures, and recapitalizations, as well as debt and public equity investments. Notable investments sponsored by Golden Gate Capital include Infor, Neustar, Vector Solutions and 2020 Technologies. For more information, visit www.goldengatecap.com.

About Bon Secours Mercy Health: For nearly 200 years, the historical founders of Bon Secours Mercy Health have been providing care to those in need. Today, the ministry is one of the top 20 health systems in the United States and part of the top performing quartile of Catholic health systems for lowest cost per case for patient care. This quality care is provided by more than 57,000 employees serving communities throughout Florida, Kentucky, Maryland, New York, Ohio, South Carolina and Virginia. The healthcare ministry provided care for patients more than 10.3 million times in 2017 through its network of more than 1,000 care sites, including more than 40 hospitals, more than 50 home health agencies, hospice agencies, and skilled nursing and assisted living facilities. Consistent with its commitment to serve each patient with dignity, Bon Secours Mercy Health provides nearly $2 million per day in community benefit. The Mission of Bon Secours Mercy Health is to extend the compassionate ministry of Jesus by improving the health and well-being of its communities and bring good help to those in need, especially people who are poor, dying and underserved. For more information, visit www.bsmhealth.org.

Contacts

For Ensemble Health Partners:
Kendall Herold
Public Relations Manager
(859) 620-1222
Kendall.Herold@EnsembleHP.com

For Golden Gate Capital:
David Isaacs / Hayley Fahey
Sard Verbinnen & Co
(415) 618-8750 / (310) 201-2040

For Bon Secours Mercy Health:
Maureen Richmond
Vice President, Integrated Communications
(513) 222-3451
mnrichmond@mercy.com

Paris, May 23,2019 –Eurazeo Patrimoine, Eurazeo’s investment division specializing in real estate and companies holding and operating real assets, announces the acquisition of the Belledonne Clinic,located near Grenoble(Isère, France) by C2SGroup. Created in 1967 in Saint-Martin-d’Hères,near Grenoble, the Belledonne Clinic offers a diversified and comprehensive range of medical services organized around seven activity sectors and particularly, cardiology, cancer surgery and maternity services. It has a capacity of 290 medical beds and 23 procedure rooms, thus becomingC2S Group’s largest clinic. Its reputation is regularly upheld by national private hospitals rankings.

With over 1,900 beds and places and an annual revenue of around €250 million, C2S Group is a major private hospital player in France. It is present in the Rhône-Alpes Auvergne and Bourgogne Franche-Comtéregions, where it has 14 clinics. C2S Group comprises around 710 doctors, who are partners in the Group’s governance, and nearly 2,500 employees. Through its presence in the Center-East region, combining state-of-the-art and local establishments, C2S Group clinics treat over 300,000 patients each year.

Eurazeo Patrimoine has supported C2S’s development since its acquisition in March2018, backing the Group’s external growth policy and helping it invest in capacity and modernization to strengthen the quality and attractiveness of its clinics.Eurazeo Patrimoine contributes financial and human resources and its investment and real estate transformation experience. The integration of the Belledonne Clinic in the Group forms part of this strategy and is a major step in C2S’s development, confirming its position as a key player in the Center-East region.

Renaud Haberkorn,Director of Eurazeo Patrimoine said: “We’re delighted to support C2S in its acquisition of the Belledonne Clinic, a top-tier asset both on operations and real estate level. The management team has demonstrated its ability to rapidly expand the Group, both organically and through instrumental acquisitions.

Eurazeo Patrimoine supports and encourages C2SGroup to achieve its ambitions.”Jean Rigondet, Chairman of C2SGroup, added: “It is essential for patients to be treated by talented practitioners, working together as a team,and to have access to well-organized and broad medical care. The acquisition of the Belledonne Clinic provides us with a high-level, comprehensive technical platform in Greater Grenoble. We’re extremely proud to integrate this reference clinic into our Group.”***

HAVAS PARISMAEL EVINE-mail: mael.evin@havas.comTel: +33 (0)6 44 12 14 91For more information, please visit the Group’s website: www.eurazeo.com Follow us on Twitter,LinkedIn, and YouTube

PRESS CONTACT EURAZEO

CONTACTS CAROLINE COHEN Head of Investor Relations ccohen@eurazeo.comTel.: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT Head of Communicationsvchristnacht@eurazeo.comTel: +33 1 44 15 76 44

About Eurazeo

Eurazeo is a leading global investment company, with a diversified portfolio of €17 billion in assets under management, including nearly €11 billion from third parties, invested in over 300 companies. With its considerable private equity, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 235 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.

Eurazeo has offices in Paris, New York, Sao Paulo,Buenos Aires,Shanghai, London, Luxembourg, Frankfurt and Madrid.

Eurazeo is listed on Euronext Paris.oISIN: FR0000121121 -Bloomberg: RF FP -Reuters: EURA.PA

About C2 SGroup

C2S Group is a multi-regional group of clinics specializing in general medicine and a leader in Auvergne-Rhône-Alpes and Burgundy Franche-Comté, with 14 clinics. C2S Group is currently implementing a sustained acquisition strategy to provide uniform and consistent geographic coverage. Medical practitioners and health professionals in these two regions are closely involved with the Group, which adopts a sustainable and high-performing outlook to human health. It has developed a patient-centric health ecosystem and is committed to offering a comprehensive range of treatments, which anticipates the needs of each patient to provide healthcare excellence.

21 May 2019

AnaCap Financial Partners(“AnaCap”), the specialist European financial services private equity firm, today announces the acquisition of a majority stake in SundhedsGruppenA/S (“SundhedsGruppen”), which consists of Dansk Sundhedssikring A/S a leading independent Danish private health insurance provider, and PrimaCare A/S a quality provider of healthcare networks.

AnaCap is acquiring the majority stake in SundhedsGruppen from the Company’s Founders, who will retain a minority.

SundhedsGruppen, provides health insurance and claims management services to clients’ employees and has built a market-leading technological infrastructure that also white labels to other providers in adjunct insurance areas.

The Company has a unique partnership arrangement with medical clinics throughout Denmark that allows for best-in-class provision of healthcare services to its customers’ employees, with a clear focus on specialist support and local availability.

SundhedsGruppen’s proprietary technological platform facilitates accurate identification of optimal healthcare access as well as reporting, feedback and claims management respectively. AnaCap will now look to leverage its deep insurance sector understanding and expertise in improving both technological and digital infrastructure to support enhancements in the customer experience as well as drive growth in new and existing markets.

The business currently provides insurance cover for approximately 250,000 individuals in Denmark, through a client list comprising several of the Nordics’ largest blue-chip companies, having grown from a founder-backed start-up in 2012. Driven by unique market positioning, the Company generated a c.70% CAGR in premiums during the period 2012-2018 vs. a 5% market norm.

AnaCap will also deploy its expertise in the insurance sector to support management’s ambition to grow market share internationally, into the Nordics and wider geographical markets, as well as through additional insurance market channels. The growth of the business will be through organic expansion models as well as identifying attractive bolt-on acquisition opportunities.

Tassilo Arnhold, Managing Director at AnaCap, comments:“AnaCap is delighted to be partnering with SundhedsGruppen.The Company has created a great insurance technology and data-driven platform with a uniquely differentiated insurer challenger proposition, high customer service standards and competitive underwriting. We are confident that our long-standing expertise in backing businesses poised for international growth will actively support this ambitious growth plan and management team, both through technological and operational investments.

” Klaus Busch, Chairman at SundhedsGruppen, comments:“By combining technology with industry expertise and a unique customer proposition, we have built a fast-growing business aiming to grow internationally and into other related industry verticals.One Stephen StreetLondonW1T 1ALPhone: +44-207-070-5250Fax: +44-207-070-5290E-mail: contact@anacapfp.comTransforming Financial Services Across Europe

We are very pleased to have identified AnaCap as a partner for the next stage of our growth and look forward to their support throughout.

”Kent Jensen, CEO at SundhedsGruppen, comments:

“We are extremely proud of the progress we have made in recent years, during which time we have built and strengthened a leading market position. Together with our highly experienced management and staff, we intend to rapidly expand our differentiated offering into new markets, both geographically and sector specific, where there is clear demand for best-in-class private health insurance.”AnaCap was advised during the process by Deloitte, Carey Olsen and Plesner.

The owners of Dansk Sundhedssikring were advised by Nordic M&A, Omera Consulting, and Moalem Weitemeyer Bendtsen.The financial details for this arrangement were not disclosed.